REG-PanGenomic Health Inc: Total Voting Rights

Pangenomic HealthAnnouncement

30/11/2023 07:15

30 November 2023

 

 

 

 

 

PanGenomic Health Inc.

("PanGenomic" or the "Company")

 

Total Voting Rights

 

Vancouver, British Columbia, Canada, 30 November 2023 - In accordance with the
FCA's Disclosure Guidance and Transparency Rules, as at 30 November 2023, the
Company's issued share capital consists of 104,967,459 Ordinary Shares of no
par value, each with one voting right. The Company does not hold any Ordinary
Shares in treasury. Therefore, the total number of voting rights in the
Company is 104,967,459.

The above figure of 104,967,459 should be used by shareholders in the Company
as the denominator for the calculations by which they will determine if they
are required to notify their interest in, or a change to their interest in,
the share capital of the Company under the Financial Conduct Authority's
Disclosure Guidance and Transparency Rules.

 

For more information, please contact:

Jerry Lai, Investor Relations    Maryam Marissen, President & CEO

PanGenomic Health Inc.    PanGenomic Health Inc.

778 743 4642      778 743 4642

ir@pangenomic.com     info@pangenomic.com

 

Novum Securities Limited, AQSE Corporate Advisor

David Coffman / George Duxberry

Tel: +44 (0)207 399 9400

 

About PanGenomic Health

PanGenomic Health is a precision health company that has developed a self-care
digital platform to deliver personalised, evidence-based information about
natural treatments. The Company's initial focus is to support mental health.
Registered as a British Columbia benefit company, PanGenomic Health's mission
is to promote and improve the health and wellness of people and society by
providing a technology platform that identifies plant-based solutions tailored
to the health profile of each individual.

 



Copyright (c) 2023 PR Newswire Association,LLC. All Rights Reserved